Clinical and genetic associations with prostacyclin response in pulmonary arterial hypertension

Parenteral prostacyclin therapy is the most efficacious pharmacologic treatment for pulmonary arterial hypertension (PAH), but clinical response is variable. We sought to identify clinical, hemodynamic, and genetic associations with response to prostacyclin therapy. We performed a retrospective anal...

Descripción completa

Detalles Bibliográficos
Autores principales: Halliday, Stephen J., Xu, Meng, Thayer, Timothy E., Mosley, Jonathan D., Sheng, Quanhu, Ye, Fei, Farber-Eger, Eric H., Pugh, Meredith E., Robbins, Ivan R., Assad, Tufik R., West, James D., Brittain, Evan L., Hemnes, Anna R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6134494/
https://www.ncbi.nlm.nih.gov/pubmed/30142026
http://dx.doi.org/10.1177/2045894018800544

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6134494/
https://www.ncbi.nlm.nih.gov/pubmed/30142026
http://dx.doi.org/10.1177/2045894018800544

Ejemplares similares